André Struglics
11 – 20 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
- Contribution to journal › Article
- 2022
-
Mark
Quantification of chondroitin sulfates and hyaluronan in synovial fluid using high performance liquid chromatography
(2022) Osteoarthritis Research Society International In Osteoarthritis and Cartilage 30(Suppl 1). p.106-106
- Contribution to journal › Published meeting abstract
-
Mark
Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
- Contribution to journal › Article
-
Mark
Novel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan
- Contribution to journal › Article
-
Mark
Associations Between Physical Activity, Self-reported Joint Function, and Molecular Biomarkers in Working Age Individuals With Hip and/or Knee Osteoarthritis
- Contribution to journal › Article
-
Mark
Osteoarthritis endotype discovery via clustering of biochemical marker data
- Contribution to journal › Article
-
Mark
Biological variation of human aggrecan ARGS neoepitope in synovial fluid and serum in early-stage knee osteoarthritis and after knee injury
- Contribution to journal › Article
-
Mark
Technical performance of a proximity extension assay inflammation biomarker panel with synovial fluid
- Contribution to journal › Article
-
Mark
The alarmins high mobility group box protein 1 and S100A8/A9 display different inflammatory profiles after acute knee injury
- Contribution to journal › Article
